Management of Vitamin B12 Deficiency
Oral vitamin B12 supplementation at doses of 1000-2000 μg daily is as effective as intramuscular administration for most patients with confirmed B12 deficiency, while intramuscular therapy should be reserved for patients with severe deficiency, neurological symptoms, or malabsorption issues. 1
Diagnosis and Assessment
Before initiating treatment, consider:
Risk factors for B12 deficiency:
Laboratory assessment:
- Complete blood count
- Serum vitamin B12 level
- Methylmalonic acid (MMA) to confirm deficiency in asymptomatic high-risk patients with low-normal B12 levels 2
Treatment Algorithm
1. Initial Treatment
For patients WITHOUT malabsorption or severe neurological symptoms:
- Oral B12 therapy: 1000-2000 μg daily 1
- As effective as parenteral therapy for most patients
- More convenient and less invasive
For patients WITH malabsorption, severe deficiency, or neurological symptoms:
- Intramuscular hydroxocobalamin:
2. Maintenance Therapy
For patients with reversible causes:
- Continue treatment until the underlying cause is addressed
- Monitor with follow-up testing within 3 months to verify normalization 1
For patients with irreversible malabsorption:
- Intramuscular hydroxocobalamin: 1000 μg monthly 1, 5
- Note: Up to 50% of individuals may require more frequent administration (every 2-4 weeks) to remain symptom-free 5
For specific populations:
- Post-bariatric surgery: 1000 μg oral B12 daily indefinitely 1
- Ileal resection >20 cm: 1000 μg intramuscular B12 monthly for life 1
- Vegans/vegetarians: 250-350 μg daily or 1000 μg weekly oral supplementation 1
Important Clinical Considerations
Never administer folic acid before treating B12 deficiency as this may mask hematologic manifestations while allowing neurological damage to progress 1
Monitor serum potassium closely during the first 48 hours of treatment and administer potassium if necessary 3
Titration based on biomarkers such as serum B12 or MMA is not recommended; instead, adjust treatment frequency based on clinical response and symptom control 5
Follow-up testing should be performed within 3 months after supplementation to verify normalization, with long-term monitoring for those with ongoing risk factors 1
The NICE guideline suggests that higher doses of oral B12 (100-150 μg daily) may be more effective and provide greater health benefit as a larger amount of B12 is delivered to the bloodstream 6
Route of Administration: Oral vs. Intramuscular
While traditional teaching has favored intramuscular administration, recent evidence shows that high-dose oral therapy (1000-2000 μg daily) can be as effective as intramuscular injections for most patients 1, 2. However, the most recent evidence suggests that for patients with malabsorption issues, oral supplementation may be insufficient, and parenteral (intramuscular) administration is preferred 5.
The choice between oral and intramuscular routes should consider:
- Severity of deficiency
- Presence of neurological symptoms
- Underlying cause (especially malabsorption)
- Patient preference and adherence